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We are investigating a new technique for myocardial revascularization in 
which an 800 W carbon dioxide laser is used to drill 1 mm diameter channels 
into a beating heart after left thoracotomy. Clotting occludes the channels on 
the subepicardium, and in the long-term setting, blood from the left ventricular 
cavity flows through these channels to perfuse the ischemic subendocardium. 
To test the efficacy of this technique in a preliminary clinical trial, we used it 
as sole therapy for 21 consecutive patients. All patients had hibernating 
myocardium, reduced coronary flow reserve, or both, had distal diffuse 
coronary artery disease, and had angina refractory to normal therapy. Eight 
patients were excluded from follow-up because of death (n = 5), rerevascular- 
ization (n = 2), or diaphragmatic paralysis resulting in postoperative respi- 
ratory incapacity (n = 1). In the remaining 13 patients available for follow-up, 
the mean angina class (Canadian Cardiovascular Society) was 3.7 - 0.4 before 
operation and 1.8 - 0.6 12 months after operation (p < 0.01). Mean resting left 
ventricnlar ejection fraction was 48% +- 10% before operation and 50% _ 8% 
at 12-month follow-up. At 12 months, resting mean subendocardial/subepicar- 
dial pcrfusion ratio had increased by 20% -+ 9% in septal regions treated by 
laser but decreased by 2% -+ 5% in untreated regions (n = 11,p < .001). These 
results suggest hat revascularizafion by this laser technique positively affects 
subregional myocardial perfusion and may result in clinical benefits for 
patients with reversible myocardial ischemia. Studies to date have not dem- 
onstrated significant changes in global and regional ventricular contractile 
function. (J THO~C CARDIOVASC SURG 1996;111:791-9) 
A fter the description of the Beck 1 and Vineberg 2procedures, Massimo and Boffi 3 reported in 1957 
the experimental results of implanting a T-shaped 
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plastic tube into the myocardial wall to bring oxy- 
genated blood from the left ventricular cavity into 
the ischemic myocardium. Needle acupuncture to 
salvage the ischemic myocardium was proposed by 
Sen and coworkers 4 in 1965. On the basis of Sen and 
coworkers' report and after experimentation in their 
own laboratory, White and Hershey 5 reported the 
successful restoration of normal ventricular rhythm 
in a 61-year-old man with myocardial ischemia nd 
resultant refractory ventricular fibrillation. Revascu- 
larization was accomplished with prolonged inter- 
mittent cardiac compression and transmyocardial 
acupuncture with a 2.5 mm knobbed cannula. The 
cannula was used to create 85 channels on the left 
ventricular free wall and 15 channels on the right 
ventricular free wall before double internal mam- 
mary arterial implantation and omentopexy. Their 
patient was free of symptoms at the tenth postoper- 
ative month. In 1968, Sen and associates 6 reported 
the results of early clinical trials with four patients. 
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Table I. Preoperative patient characteristics 
Patients (n = 21) 
Characteristics No. % 
Previous MI 
Anterior 3 14 
Inferior 8 38 
Anterior + inferior 1 5 
Previous revascularization 
(CABG or PTCA) 
None 2 10 
1 8 38 
->2 12 57 
Concurrent illnesses 
Congestive heart failure 11 52 
Arrhythmias 10 48 
Diabetes mellitus 3 14 
CABG, Coronary artery bypass grafting; PTCA, percutaneous translurninal 
coronary angioplasty. 
In 1969, Sen 7 suggested that multiple myocardial 
acupunctures result in improved contractility or 
rapid electrical defibrillation in acute pump failure 
after prolonged cardiopulmonary bypass. He also 
speculated that the technique would be useful for 
the surgical treatment of acute and chronic coronary 
occlusion and the intermediate coronary syndrome. 
In 1981, Mirhoseini and Cayton s first proposed 
using a laser to create transmyocardial channels. 
Mirhoseini, Fisher, and Cayton 9were the first to use 
this technique in a patient whose heart was not 
beating. 
Okada and colleagues 1°first used an 85 W carbon 
dioxide laser to create six holes in the contracting 
anterior left ventricular wall of a 55-year-old man with 
constrictive pericarditis and severe angina. They re- 
ported improved clinical outcome 9 months after the 
operation. Since 1990, a high-powered carbon dioxide 
laser (800 W) has been used to perform transmyocar- 
dial laser revascularization (TMLR) on the beating 
hearts of human beings. TM 12 
More recently, we reported 6-month follow-up 
results of TMLR with the 800 W carbon dioxide 
laser. The technique was used as sole therapy in 
patients who had distal diffuse coronary artery dis- 
ease; hibernating myocardium, reduced coronary 
blood reserve, or both; and angina refractory to 
normal therapy. 13 We report here the 12-month 
postoperative r sults of these patients. We believe 
that it is important to document our experience 
across a longer interval because this new treatment 
modality, if substantiated by time and by other 
investigators, could have an important implication 
for the surgical treatment of coronary artery disease. 
Methods 
Patients. Patients were enrolled in the study after 
signing a consent form approved by the Institutional 
Review Board of St. Luke's Episcopal Hospital. Twenty- 
one consecutive patients (mean age 63 _+ 10 years, 14% 
female) were treated with the laser as sole therapy after 
documentation by positron emission tomography (PET) 
of perfusion defects in the left ventricular free wall. Of 
these patients, four (19%) had unstable angina when 
enrolled in the study and seven (33%) had a left ventric- 
ular ejection fraction (LVEF) of 35% _+ 5%. Other 
relevant preoperative characteristics of patients are given 
in Table I. 
Patient evaluation and data analysis. Patients were 
evaluated before operation and 12 months after operation 
with PET for myocardial ischemia nd viability, TM and with 
dobutamine chocardiography for regional wall motion 
analysis and LVEF at rest and during stress. 15 Thallium 
201 single-photon emission computed tomography (2mT1- 
SPECT) was used to determine myocardial perfusion at 
rest and during stress, and multigated acquisition radio- 
nuclide ventriculography was used to determine LVEF at 
rest. Stress was induced in patients with stable angina on 
a treadmill with a modified Bruce protocol before the 
amT1-SPECT test. 13 Time on the treadmill was recorded 
for each patient and averaged for baseline and for the 
follow-up period. Patients who could not exercise for 
reasons unrelated to heart disease did not undergo a 
treadmill test. 
Data from PET, dobutamine chocardiography, and 
2°IT1-SPECT tests were analyzed in short-axis projections 
of the myocardium at basal, middle, and distal levels. 
Regions of interest at each level were identified as septal, 
anterior, lateral, and inferior. The septum was further 
subdivided into inferoseptal nd anteroseptal segments at 
the basal and middle levels; the apex was considered an 
independent segment. 
For PET analysis, the relative perfusion was measured 
for transmural regions and for subendocardial nd sub- 
epicardial subregions. Perfusion values from the PET 
measurements were used to calculate subendocardial/ 
subepicardial perfusion ratio (SEn/SEp). 
Regional myocardial wall motions observed uring do- 
butamine echocardiography were assigned subjective 
scores of 1 (normokinetic), 2 (hypokinetic), 3 (akinetic), 
or 4 (dyskinetic). The wall motion score index (WMSI) 
was calculated by separately averaging the scores of lased 
(anterior, lateral, and inferior) and nonlased (septal and, 
in some cases, basal inferior) segments. 
Regional myocardial viabilities assessed from 2mT1- 
SPECT were assigned scores of 4 (normal), 2 (ischemic), 
1 (ischemia round scar), and 0 (scar) on the basis of 
subjective assessment of perfusion at peak stress and 
redistribution. Individual scores were averaged separately 
among lased and nonlased regions. 
Statistical analysis. The statistical significance of the 
differences between the lased and nonlased regions at 12 
months, or of differences between the same regions at 
baseline and 12 months, were analyzed with a paired, 
two-tailed Student's t test. 
Surgical procedure. Patients were intubated with a 
double-lumen Carlson tube. A left anterolateral thoracot- 
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Table II. Clinical characteristics of 13 patients 
before operation (baseline) and 12 months after 
operation 
Baseline 12 mo 
Angina class* 3.7 -+ 0.4 1.8 +- 0.6t 
Time on treadmill (rnin) 4.3 _+ 2.1 10.0 -+ 3.8t 
*Canadian Cardiovascular Society classification. 
?p < 0.001. 
omy was performed at the fourth intercostal space. The 
left lung was deflated. If intrapericardiac dhesions were 
present as a result of previous coronary artery bypass 
operations, they were dissected. The heart was placed in a 
pericardial cradle. A sterile focusing end-piece coupled to 
the articulating arm of the 800 W carbon dioxide Heart 
Laser (PLC Medical Systems, Inc., Milford, Mass.) was 
brought into the surgical field draped in a sterile cover. An 
end-piece with a mirror mounted at the tip to deflect he 
output laser beam by 90 degrees was used to create 
channels in the proximal diaphragmatic aspect of the left 
ventricular f ee wall. Detection of intraventricular micro- 
bubbles by transesophageal chocardiography was inter- 
preted as confirmation of the transmural penetration of
each pulse. Multiple full-thickness laser perforations of 
the contracting myocardium were induced and confirmed, 
predominantly in the regions determined before opera- 
tion to exhibit ischemia in viable myocardium. Because 
the infrared wavelength at which the carbon dioxide laser 
emits radiation (A = 10,660 nm) is highly absorbed by 
fatty tissue as well as by water, the output pulse energy of 
the laser was increased from an initial value of 15 J to a 
maximum of 60 J when excessive epicardial fat precluded 
full penetration at the lower power. Hemostasis was 
ensured with external digital pressure or, rarely, epicardial 
purse-string sutures. The incision was closed routinely. 
Results 
Perioperative. An average of 36 +_ 5 pulses were 
delivered per patient, with 76% confirmation by 
transesophageal echocardiography. The periopera- 
tive mortality and morbidity associated with the 
procedure have been reported in detail elsewhere. 13
Briefly, a 64-year-old man had right-sided hemidia- 
phragmatic paralysis immediately after operation; a
47-year-old man had a brief episode of atrial tachy- 
rhythmia 3 days after operation (the arrhythmia was 
successfully managed medically); a 72-year-old 
woman died of ventricular tachyrhythmia 5 days 
after operation, possibly caused by a perioperative 
infarct observed during cardiac autopsy; and an 
80-year-old man with preoperative chronic obstruc- 
tive pulmonary disease and angina decubitus died of 
aspiration pneumonia 8 days after operation. With 
the exception of this last man, no patient required 
inotropic support in the perioperative phase. 
Table III. Mean LVEF before operation (baseline) 
and 12 months after operation 
LVEF (%) 
Analytic method Baseline 12 mo 
MUGA (resting n = 12) 48 _+ 10 50 _+ 8 
Dobutarnine chocardiography 
(n = 10) 
Rest 41 _+ 10 41 _+ 12 
Stress 45 -- 11 48 _+ 17 
MUGA, Multigated acquisition radionuclide ventriculography. 
Twelve-month follow-up. A 56-year-old man died 
of an inferior myocardial infarct 94 days after oper- 
ation, a 77-year-old man died of renal insufficiency 
97 days after operation, and a 72-year-old woman 
died of a refractory ventricular fibrillation 287 days 
after operation. Two patients were rerevascularized 
87 and 91 days after laser operation with bypass 
grafting and coronary angioplasty, respectively, to 
treat new lesions. 
The eight patients excluded from follow-up at 12 
months were the 5 who died, the two who had 
rerevascularization, and the one whose 12-month 
rerevascularization was postponed until after the 
placement of a diaphragmatic pacemaker. This re- 
port therefore describes the clinical and functional 
results of the 13 patients who were reevaluated at 
the completion of the study. At 12 months after 
operation, no patients had unstable angina. Eleven 
patients reported significant relief from their preop- 
erative angina (reduction by at least two classes in 
the Canadian Cardiovascular Society angina classi- 
fication) and had either returned to work or been 
free from symptoms for the past 6 months. The 
average angina class at follow-up was 1.8 +_ 0.6, 
significantly lower than the average baseline angina 
class of 3.7 +- 0.4 (p < 0.001, Table II). The average 
time on the treadmill increased significantly at 12 
months (p < 0.001, Table II). The mean LVEFs at 
rest and during stress did not change significantly 
during the 12 months (Table III). 
Two patients did not have adequate acoustic 
windows for optimal echocardiographic study. Base- 
line and 12-month echocardiographic WMSIs at rest 
and with low-dose and high-dose dobutamine stress 
are depicted in Fig. 1. Although the resting WMSI 
in the lased regions decreased from 1.91 +_ 0.65 at 
baseline to 1.82 _+ 0.79 (that is, wall motion im- 
proved) and the WMSI in the nonlased regions 
increased from 1.82 +__ 0.79 at baseline to 1.98 +_ 0.61 
during the 12-month follow-up period, the changes, 
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Fig. 1. WMSI by echocardiographic analysis of 15 cardiac segments per patient at rest and during low-dose 
(10 /xg. kg 1. min-i) and high-dose (40 /xg.kg 1. rain-l) dobutamine infusion. 1, Normokinetic; 2, 
hypokinetic; 3,akinetic; 4, dyskinetic;p not significant for lased versus nonlased and baseline versus 12 months. 
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Fig. 2. Myocardial perfusion and viability status as a 
percentage of normal by 2°IT1-SPECT analysis of 15 
cardiac segments per patient; p not significant for lased 
versus nonlased and baseline versus 12 months. 
unlike those seen at 6-month follow-up, 13 did not 
reach a level of statistical significance. WMSIs at 
low-dose and high-dose dobutamine stress deterio- 
rated for both the lased and the nonlased segments 
during the 12-month follow-up period (Fig. 1). 
Follow-up with 2°IT1-SPECT of 12 patients (one 
patient did not undergo 2°IT1-SPECT follow-up) 
Table IV. Transmural 15-segment analysis by PET 
of myocardial perfusion and viability status with 
respect o baseline in 11 patients 12 months after 
TMLR 
Lased Nonlased 
segments segments 
(free wall) (septum) 
No. % No. % 
Improved 33 30 20 36 
Same 33 30 24 45 
Worse 44 40 10 18 
Total segments 110 55 
indicated that the average perfusion of the lased 
regions increased from 45% + 21% of normal at 
baseline to 51% _+ 23% of normal at 12 months; the 
perfusion of the nonlased segments decreased from 
73% _+ 22% of normal at baseline to 70% _+ 21% of 
normal at 12 months (Fig. 2). The increase in 
perfusion in the treated segments represented an 
improvement of 13% from baseline values but was 
not statistically significant compared with the 
change in perfusion of the nonlased segments. 
Regional myocardial perfusion and viability status 
in transmural sections were monitored with conven- 
tional PET during the first year after operation. One 
patient did not have a PET study before the opera- 
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Fig. 3. Subregional nalysis of myocardial SEn/SEp by PET at rest (n = 11 patients) and during 
dipyridamole stress (n = 9 patients). Change in SEn/SEp with respect to baseline was significantly different 
in lased segments compared with nonlased segments both at rest (p < 0.0001) and under stress (p < 0.01). 
tion, however, and another patient could not be 
studied at 12 months because of technical problems. 
In the 11 patients for whom preoperative and 12- 
month follow-up PET data were available, 30% of 
the lased regions howed marked improvement a 12 
months, but 40% were worse compared with base- 
line (Table IV). Among the nonlased segments, the 
perfusion of 15% remained unchanged. 
Additionally, the relative perfusion across the sub- 
regions of the myocardium (SEn/SEp) was mea- 
sured with subregional PET analysis. At 12 
months after operation, perfusion was measured 
in 11 patients at rest and in nine patients during 
stress. The average resting SEn/SEp increased 
from 0.96 _+ 0.07 at baseline to 1.10 _+ 0.04 at 12 
months in the lased segments. SEn/SEp decreased 
from 1.07 -+ 0.07 at baseline to 1.00 _+ 0.02 at 12 
months in the nonlased control segments of the 
septum (p < 0.0001, Fig. 3). During stress, SEn/ 
SEp increased from 0.87 _+ 0.10 at baseline to 1.17 
_ 0.04 at 12 months in the lased segments and 
from 0.96 _+ 0.05 at baseline to 1.01 _+ 0.01 at 12 
months in the control segments (p < 0.01, Fig. 3). 
Discussion 
First reported by Mirhoseini, Fisher, and Cayton 9
in 1983, TMLR is a relatively new therapeutic 
modality for patients with coronary artery disease. 
In this study we wished to measure objective ira- 
Table V. A 2 × 2 table for evaluating accuracy and 
sensitivity of subregional 15-segment myocardial 
perfusion analysis by PET in accordance with 
clinical status after TMLR (n = 11) 
Clinical status 
Analysis by PET Better Same 
Bet ter  8 1 
Worse  1 1 
Accuracy = (True positives + True negatives)/All cases = (8 + 1)/11 = 
82%. 
Sensitivity = True positives/(True positives + False negatives) = 8/(8 + 1) 
- 89%,  
provement in myocardial perfusion when the laser 
was used as the sole treatment for such patients. Our 
access to and long experience with PET in the 
assessment of myocardial viability and perfusion 
prompted our use of this modality in the hope of 
obtaining the most accurate available assessment 
of the laser technology. In this preliminary study of 
limited size, patients with documented coronary 
artery disease and reversible myocardial ischemia 
had a significantly improved clinical status and a 
markedly increased treadmill tolerance 12 months 
after TMLR was used as a sole therapy. The echo- 
cardiographic WMSIs and LVEFs at rest and during 
stress, however, remained unchanged by dobut- 
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amine. Regional myocardial peffusion by 2°ITI- 
SPECT showed positive, although not significant, 
trends toward improvement. In contrast, studies by 
PET did indicate a significant change in relative 
subendocardial perfusion. 
The myocardial perfusion and viability status were 
assessed by PET on short-axis projections within trans- 
mural regions as well as within subendocardial nd 
subepicardial subregions. Transmural analysis of the 
110 lased segments in the left ventricular f ee wall of 
11 patients revealed that the peffusional nd metabolic 
status in 33 segments (30%) was better at 12 months 
than at baseline and that the status in the remaining 
70% of the segments was either unchanged or worse at 
12 months (Table IV). Because nine of the 11 patients 
(82%) reported significantly improved anginal symp- 
toms, the results of transmural PET analysis were in 
poor agreement with the clinical condition of the 
patients. Subregional PET analysis, however, evealed 
that SEn/SEp had increased by at least 15% over 
baseline in eight of the nine patients with improved 
clinical status and decreased by 1% in one of the two 
patients whose anginal symptoms were unchanged 
after operation (Table V). Overall, the 12-month 
subregional PET analysis represented the clinical sta- 
tus of the patients with an accuracy of 82% and a 
sensitivity of 89%; by similar calculations, the transmu- 
ral PET analysis had an accuracy of 55% and a 
sensitivity of 44%. 
Subregional PET analysis involves the differenti- 
ation of the subendocardial perfusion (which is 
expected to increase if the laser channels connect 
with myocardial sinusoids and remain functional) 
from the subepicardial peffusion (where no change 
is expected because the peripheral portion of the 
channel is sealed immediately by clot formation). In 
transmural analysis, however, tracer concentration 
is averaged by the computer across the myocardial 
thickness, sacrificing in part the sensitivity of the 
calculations to changes in perfusion in the radial 
direction. In that regard, our results upport he use 
of subregional PET analysis in patient selection and 
follow-up for TMLR. 
The reversal of SEn/SEp at 12 months in favor of 
subendocardial perfusion indirectly suggests the pa- 
tency of the laser channels. The finding of endothe- 
lialized laser tracts connecting with native myocar- 
dial vessels has been reported in an isolated casel2; 
however, such direct evidence of channel patency 
and functionality is currently scarce. It is therefore 
not clear whether the majority of laser-induced 
channels indeed remain open for prolonged times or 
whether the observed clinical and perfusional effects 
of the procedure are mediated through other mech- 
anisms. For example, the thermal, mechanical, or 
oxidative stresses associated with the insult may 
elicit adaptive responses and mediate angiogenesis 
in the laser-treated zones.  16' 17 These possibilities 
should be assessed in experimental models that (1) 
correctly represent he collateral-dependent a at- 
omy of the hibernating human myocardium and (2) 
use the relevant laser parameters. In contrast with 
such alternative modalities as the low-power carbon 
dioxide laser TM or the Ho:YAG laser, 19 which have 
been proposed and used experimentally in TMLR, 
current carbon dioxide laser technology can achieve 
high pulse energies to cross the contracting myocar- 
dium in a fraction of a single cardiac cycle. This 
minimizes the incidence of arrhythmias and allows 
the creation of straight laser tracts with smooth 
edges. The high absorption/scattering ratio of the 
photons at this wavelength, on the other hand, keeps 
the collateral damage to cardiovascular tissue at a 
minimum. 2° 
Because this preliminary study lacked a control 
group, the results in no way validate TMLR as sole 
treatment for obstructive coronary artery disease 
refractory to conventional treatment. The results do 
demonstrate, in an extensive longitudinal follow-up 
with 50 PET scans at scheduled intervals, statisti- 
cally significant improvement in relative subendo- 
cardial perfusion consistent with the clinical im- 
provement observed in most (9/11) patients. We 
therefore believe that further evaluation of the 
efficacy of TMLR in the clinical setting is warranted. 
Larger clinical trials with appropriate control groups 
would be useful in evaluating the clinical value and 
potential of this promising technology. 
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Discussion 
Dr. Lawrence H. Cohn (Boston, Mass.). We have used 
this same high-energy heart laser at the Brigham since 
March of 1993, after about a year's work in our laboratory 
before that done by my colleague, Dr. Keith Horvath. We 
have used similar indications. We have only used this laser 
in the isolated situation, without any concurrent opera- 
tion. A refereed group of physicians at our hospital proved 
that these patients were not candidates for cardiologic 
intervention or operation. They definitely had to have 
reversible ischemia. We believe that this therapy is not 
good for ischemic ardiomyopathy; therefore, the ejection 
fraction should be at least 30%. 
Similar to the group presented here, these are patients, 
mostly men, with very advanced coronary disease. Seven- 
teen of our 19 patients in whom only this therapy was used 
had a previous operation, very severe angina class, and a 
mean ejection fraction of 45%. 
To evaluate any changes in myocardial perfusion, we 
have used a computerized polar map by the use of 
sestamibi thallium scans. We have results for 11, 10, and 7 
patients at 3, 6, and 12 months after operation, respec- 
tively. The septa! flow, which is not lased, shows virtually 
no change in myocardial perfusion. Conversely, in the free 
wall, correlating with areas in which we did perform laser 
drilling, there are significant increases in perfusion both at 
rest and with stress at 3, 6, and 12 months after operation, 
suggesting tous that this modality did increase myocardial 
perfusion, 
Finally, we have been performing the technique lately in 
the laboratory with the help of Dr. DeGuzman. We have 
used this technique through a thoracoscope in a 35 kg 
porcine model where obviously there was no previous 
operation, Through a thoracoscope, this procedure could 
be done in anyone with a free pericardium. The cutting of 
the pericardium and finally use of the laser probe to make 
appropriate channels can be seen through the thoraco- 
scope. This procedure has been done in five animals, all of 
which have survived. 
I have two questions. Do the results in the PET scans 
that you have done correlate with the drilled areas; in 
other words, does increased nutrition correlate with where 
you actually drilled? Finally, how can you, if at all possible, 
evaluate the laser treatment inthose patients in whom you 
did a concomitant coronary bypass? 
Dr. Frazier. I think the laser has shown its value, 
particularly in these PET scan studies. Moreover, Dr. 
Gould, who has had extensive xperience with PET scan- 
ning and who was originally very skeptical of TMLR, has 
confirmed that TMLR generally results in improvement i  
these patients, especially in the endocardial area. Of 
course, when TMLR is combined with other procedures, it 
is very difficult to assess the laser's effect; therefore, I do 
not believe that combined procedures are going to help 
establish the value of TMLR. I have the clinical impres- 
sion, however, that acutely ill patients whose status is 
decompensated--such as the two patients in our series 
who underwent TMLR after sustaining a myocardial 
infarction--are better suited to demonstrating the true 
worth of this technique. For the technique to gain ap- 
proval and widespread use, we will have to depend on 
scientific data, such as is being accumulated in cases in 
which TMLR is the sole means of therapy. 
Dr. M. Mirhoseini (Milwaukee, Wis.). TMLR has had a 
long journey. Since 1969, after Sen's operation with the 
needle, we developed the concept of using a carbon 
dioxide laser to drill these channels. This is based on the 
following technical criteria: a laser powerful enough to 
penetrate the thickness of the left ventricular myocar- 
dium; short pulse duration to prevent lateral thermal 
injury, which is very important; he carbon dioxide laser, 
when it reaches the water, stops at 10.6/,m of energy; and 
laser energy triggered by electrocardiography in the non- 
vulnerable phase of the R wave of PR intervals prevents 
arrhythmia nd arrives at the ventricular cavity during 
diastole, when the heart is filled. 
Initially we did extensive research on this. Publications 
are available, and the results of the research were pub- 
lished in the Journal of Microsurgery and also published 
after presentation to the World Congress of Cardiac 
Surgery in Detroit. We had trouble bringing this to the 
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clinical standard in the operating room, however, because 
such a large laser required very big modifications. The 
next step for us was therefore to use a smaller, lower- 
powered laser and use the laser in the arrested heart 
during cardiopulmonary b pass, for which we received 
clinical permission from the Institutional Review Board of 
St. Luke's Medical Center. The research was mostly done 
at the Medical College of Wisconsin. Some of these cases 
were initially presented at the Society of Thoracic Surgery 
meeting in Toronto and were published in the Annals of 
Thoracic Surgery. In some of these patients who under- 
went combined operation, 3 or 4 years after operation we 
could demonstrate some of these laser channels with 
angiography by a special technique of cineangiography 
with high resolution. 
The series of operations that we performed on 30 
patients between 1985 and 1987 involved combined pro- 
cedures. Then a new high- energy laser was developed by 
PLC Systems here in Boston, so we could use this 800 W 
laser for the procedure to make these channels. 
I would like to bring to your attention the last series of 
procedures. There were 42 in this study. Three of them 
were eliminated because they were done on transplanted 
hearts. Thirty-nine patients had been under study. I 
congratulate Drs. Frazier Cooley on their excellent re- 
sults, Our results are very similar to their results with 
respect to clinical follow-up, selection of patients, and 
criteria for using the laser. Most of these patients are in an 
older age group and are sick patients with previous 
multiple coronary artery bypass grafts and angioplasties. 
Angina subsides or disappears in most patients, but there 
is a rate of attrition in 2 years after operation. Now a few 
of them are coming back with angina. Although regional 
wall motion improves, the overall ejection fraction does 
not seem to change. 
You demonstrated that the subendocardium perfused 
better in your paper that I reviewed. To what do you 
attribute that better perfusion in the endocardium? Which 
is the higher pressure level of the myocardium? 
Dr. Frazier. Anatomically, most of the sinusoids are 
concentrated in the endocardium, so if TMLR is going to 
result in improved perfusion, that is where most improve- 
ment will be seen. In using PET scanning to assess the 
results of TMLR, we were not so impressed with this 
method until we analyzed the endocardial nd epicardial 
regions eparately, which is not normally done. By analyz- 
ing each region separately, we found a statistically signif- 
icant degree of improved endocardial perfusion in these 
patients. 
We are all indebted to Dr. Mirhoseini for this early 
experimental work. Obviously, continued studies are nec- 
essary to define the role of TMLR in the care of these 
challenging patients. 
Dr. Craig R. Smith (New York, N.Y.). We have had a 
remarkable relief of angina in a very small series of 
patients treated at Columbia Presbyterian recently with 
the carbon dioxide laser. We have a much longer experi- 
ence trying to develop a percutaneous alternative with a 
holmium laser. Based on this experience, I will make two 
brief comments and ask one question. 
Experimentally, we have looked at an isolated heart 
model that completely separates coronary perfusion from 
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ventricular blood and have been unable to show any 
quantitatively significant flow through these channels. 
This is at odds with our own experimental findings and 
those of Horvath, Cohn, and others, which have shown 
reversal of acute ischemia in lased regions. Second, after 
a fairly exhaustive 10ok at many specimens with the carbon 
dioxide and the holmium lasers, we have been unable to 
find what we would describe as patent channels. I think 
what we do see is interesting. We see irregular endothe- 
lium-lined spaces occupying columns of intense neovascu- 
larity at the sites of channel formation, and I suggest that 
this may turn out to be a more accurate description of 
what was shown today. This is consistent with perhaps a 
more chronic mechanism and is also consistent with a 
more delayed improvement in scan findings, for example, 
but it is not consistent with the prompt relief of angina 
that is so often reported. That is another unresolved 
paradox. 
In your autopsied specimens, how many out of the 
number of channels you know you have created have you 
identified and sectioned, and are the results consistent? I 
add my plea that the question of efficacy be answered in 
patients where this is used as sole therapy before we 
advocate widespread use as adjunctive therapy, because I 
think we still have a lot to learn. 
Dr. Frazier. I think that your first allusion was to a 
different ype of laser, using a different method; it there- 
fore can be related only to the experimental nimal in 
which it was used. I do not believe that you can draw any 
clinical conclusions about it one way or the other. It was a 
research experiment in which you were not able to show 
any perfusion. In that experiment, the laser approach was 
from the inside out, which is different from that of the 
TMLR. In our method, the use of a high-energy carbon 
dioxide laser is important o create effective channels. 
Although the energy is quite high, it causes little lateral 
damage. I believe that the character of the high-energy 
carbon dioxide laser delivered externally has clinical po- 
tential. 
I think that neovascularization does occur and may play 
an important role in the improved perfusion we have 
demonstrated. I also think that the laser channels remain 
open. In fact, other experiments have shown them to be 
open, even in the dog, which is a poor model. I als0 
believe that there are patients in whom these channels do 
not stay open. The channels were open in our patient who 
died at 3 months, however, and another patient of Dr. 
Mirhoseini's, who died at 3 years and in whom open 
channels were demonstrated. Nevertheless, their precise 
contribution to blood flow is unknown and is a fitting 
subject for future research. Clearly, patients with severe 
coronary artery disease will have a proliferation of sinu- 
soidal lakes and may therefore be more likely to benefit 
from TMLR. Our goal now is to define the patient group 
that will benefit most from this procedure. 
Dr. Hassan Najafi (Chicago, Ill.). With a measurable 
degree of skepticism, about a year ago I consented to have 
our institution, Rush-Presbyterian-St. Luke's, become 
involved in this project. Dr. Robert March, one of my 
younger associates, pursued this and during the ensuing 
many months performed the procedure in 22 patients. 
I confine my brief remarks to the 15 patients who 
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underwent this procedure as their sole modality of treat- 
ment. These patients had had an average of two previous 
coronary bypass operations and some five or six percuta- 
neous transluminal coronary angioplasties. They were in 
class IV, were not candidates for cardiac transplantation, 
and were mostly homebound. This operation was per- 
formed with no mortality, no complications, and a length 
of stay of 7 days. With the exception of one patient, who 
remains in class IV, the patients have had significant 
subjective improvement, which has been supported by 
conventional noninvasive studies howing improvement of
perfusion to ischemic segments of the myocardium. I am 
no longer skeptical about this procedure. For a patient in 
class IV for whom there is no other operation or treat- 
ment and who wishes to have this operation performed, 
because it is a rather safe procedure, I think that it is a 
reasonable adjunct o our armamentarium for treatment 
of patients with coronary artery disease. 
Dr. Rodney J. Landreneau (Pittsburgh, Pa.). I would like 
to state that I do not believe that this procedure should be 
considered as a primary means of achieving acute myo- 
cardial revascularization. We have evaluated the effect of 
TMLR on regional myocardial perfusion and regional 
wall motion function in the acute canine ischemic model. 
Radioactive microsphere distribution, myocardial pH, and 
local high-energy phosphate moiety concentrations were 
assessed in the left anterior descending distribution before 
and after control occlusion and after occlusion and 
TMLR. Sonomicrometric assessment of regional wall 
motion was also performed. Blood flow, tissue pH, high- 
energy phosphate concentrations, and ventricular wall 
motion were predictably disturbed after left anterior 
descending occlusion. TMLR resulted in no acute im- 
provement in any of these parameters. 
The physiologic data presented here support he idea 
that the benefit of TMLR results from augmenting re- 
gional collateral flow to the ischemic myocardium at risk 
by augmenting endocardial- myocardial sinusoidal con- 
nections and possibly by creating bridges across watershed 
regions within the myocardium. The effect obviously takes 
time to develop, as documented by the late improvement 
seen in this group. I wonder whether this group has looked 
at the possibility of further enhancement in collateral 
development in these regions in their laboratory, perhaps 
along the same line of delivery that Dr. Wayne Isom's 
group is looking at with angiogenic factors being locally 
instilled. We have a debt of gratitude to Drs. Sen, Beck, 
Vineberg, and Mirhoseini for their pioneering efforts in 
these areas of direct myocardial revascularization. 
Dr. Frazier. We performed an animal experiment sim- 
ilar to that described by Dr. Landreneau, and we were 
unable to show short-term improvement in an exact 
canine model, but our long-to ~m studies did show statis- 
tically significant improvement. Our results will be ap- 
pearing in an upcoming issue of Lasers in Medicine, and I 
believe that they show the importance of similar animal 
studies. In the long run, however, I am not sure how 
seriously such studies can be taken, because the animals 
do not model the condition that we will be addressing 
clinically. 
I appreciate Dr. Najafi's comments. The patient group 
in question is an extremely challenging one, and it dem- 
onstrates the feasibility of performing TMLR in very sick 
patients. Nevertheless, the degree of benefit must be 
clearly defined and studied, along with such fundamental 
issues as the number of laser channels that should be 
made in a given patient, the optimal energy level of the 
laser, and other important mechanical factors. 
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